New heartburn pill may change how blood thinners work after stent placement
NCT ID NCT07471867
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a new drug called ZaStaprazan affects how well the blood thinner clopidogrel works in people who have had a heart procedure (stent placement). About 100 adults with chronic coronary syndrome will take either ZaStaprazan or a standard heartburn drug (PPI) for one month. The main goal is to measure blood clotting activity to see if ZaStaprazan is a safer option for managing stomach acid without interfering with heart medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yongin Severance Hospital, Yonsei University
RECRUITINGYongin-si, Gyeonggi-do, 16995, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a trained eye match ultrasound for heart stent placement?
- Could a quicker, cheaper scan replace the gold standard for heart blood flow?
- Could a neck ultrasound replace heart CT scans for chest pain patients?
- Fish oil derivative may calm heart inflammation and stabilize plaques
- Heart stent mystery: new diagnostic strategy could reveal hidden causes of Post-PCI angina
- AI-Powered ultrasound could replace CT for heart valve diagnosis